M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES

Detalles Bibliográficos
Autores principales: Abou-Jaoude, E., Nsouli, T., Diliberto, N., Nsouli, S., Bellanti, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566841/
http://dx.doi.org/10.1016/j.anai.2021.08.184
_version_ 1784594103286104064
author Abou-Jaoude, E.
Nsouli, T.
Diliberto, N.
Nsouli, S.
Bellanti, J.
author_facet Abou-Jaoude, E.
Nsouli, T.
Diliberto, N.
Nsouli, S.
Bellanti, J.
author_sort Abou-Jaoude, E.
collection PubMed
description
format Online
Article
Text
id pubmed-8566841
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-85668412021-11-04 M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES Abou-Jaoude, E. Nsouli, T. Diliberto, N. Nsouli, S. Bellanti, J. Ann Allergy Asthma Immunol Article Published by Elsevier Inc. 2021-11 2021-11-04 /pmc/articles/PMC8566841/ http://dx.doi.org/10.1016/j.anai.2021.08.184 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Abou-Jaoude, E.
Nsouli, T.
Diliberto, N.
Nsouli, S.
Bellanti, J.
M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title_full M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title_fullStr M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title_full_unstemmed M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title_short M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES
title_sort m010 diagnostic challenge in evaluating the risk and management of allergic reaction(s) to sars-cov-2 vaccines
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566841/
http://dx.doi.org/10.1016/j.anai.2021.08.184
work_keys_str_mv AT aboujaoudee m010diagnosticchallengeinevaluatingtheriskandmanagementofallergicreactionstosarscov2vaccines
AT nsoulit m010diagnosticchallengeinevaluatingtheriskandmanagementofallergicreactionstosarscov2vaccines
AT diliberton m010diagnosticchallengeinevaluatingtheriskandmanagementofallergicreactionstosarscov2vaccines
AT nsoulis m010diagnosticchallengeinevaluatingtheriskandmanagementofallergicreactionstosarscov2vaccines
AT bellantij m010diagnosticchallengeinevaluatingtheriskandmanagementofallergicreactionstosarscov2vaccines

Ejemplares similares